Pharma News

Prices of 869 formulations, including antibiotics, cancer and cardiovascular disease treatment drugs and two types of coronary stents, have gone up by 3.44%, according to the National Pharmaceutical Pricing Authority (NPPA).

• Price
• Formulation

Mumbai-based Glenmark Pharmaceuticals Ltd., and Switzerland’s Helsinn Group, have announced that they have entered into an exclusive licensing agreement to introduce Akynzeo, an oral fixed combination of netupitant (300-mg) and palonosetron (0.5-mg) ...

• Glenmark
• Helsinn

Dr. T.V. Narayana has been elected as the President of the Indian Pharmaceutical Association (IPA) for the term 2018-20. Dr. Narayana has been the Vice President & Chairperson of education division of IPA since 2008. He is currently the Principal of .

• India
• People
• IPA

Dr. Reddy’s Laboratories Ltd. (DRL) and its US subsidiary, Promius Pharma, LLC have announced the filing of a New Drug Application (NDA) for its migraine candidate DFN-02 with the USFDA.

• DRL
• US
• India

GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector-based therapeutics, including viral vector-based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio ...

• GE
• Healthcare

MilliporeSigma has introduced three new products to support flexible manufacturing of biologics. The innovations, all designed to make single-use bioprocessing easier, safer and more efficient, were unveiled at Interphex 2018, held April 17-19 in New York

• MilliporeSigm
• Product

Cambrex has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility. The investment underpins Cambrex's on-going commitment to new technologies and aims to reinforce the company's existing experience in...

• Cambrex
• Expansions

SAMDI Tech, a provider of label-free drug discovery solutions, has partnered with Enamine, a supplier of drug-like screening compounds, to expand the number of molecules in their small molecule compound libraries. Through the partnership, SAMDI Tech will

• SAMDI
• Library
• Molecules

Wacker Chemie AG has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg for an undisclosed amount.

• Wacker
• Acquisition
• Dutch

Shire has entered into a definitive agreement with Servier to sell its Oncology business for $2.4 billion.

• Shire
• Servier

AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK. Upon completion, JRI Orthopaedics will become a wholly-owned subsidiary of the Hong Kong Stock Exchange-listed AK Medical.

• AK
• Medical
• JRI
• Orthopedics

The U.S. Food and Drug Administration (FDA) finalized two separate guidances for next-generation sequencing technologies. The regulatory agency said the new guidelines will help accelerate the development of individualized genetic-based medicine as person

• FDA
• test

In assessing changes to MDR due for 2020, Forum MedTech Pharma states that safety and quality must take priority over speed. CEO Dr Matthias Schier considers, however, that implementing changes in the form of the new MDR and IVDR poses challenges for...

• MDR
• Guidance

It's no surprise that chemicals can get flushed into our water supply from the pills we take. But as the world's population grows, the rampant consumption of pharmaceuticals has become an emerging threat to the world's freshwater ecosystems, researcher...

• Environment
• Drug
• Waste

Emergent BioSolutions has successfully completed the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU), including Italy, the...

• Emergent
• Market
• Pharmaceutical

Catalent Pharma Solutions has completed a $5.5 million expansion program at its more than 200,000 square foot Philadelphia, PA, site to provide additional clinical packaging and storage capacity.

• Catalent
• Pharma
• Expansions

Novartis’ Afinitor Disperz has become the first medicine to be specifically approved by US regulators to treat patients aged two years and above with tuberous sclerosis complex (TSC)-associated partial-onset seizures.

• Novartis
• Afinitor
• Disperz

European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,000 children and adults in the EU.

• EU
• Kineret

Pharma exports, which account for 44 per cent of total merchandise exports from Telangana, are set to soar with the setting up of a new pharma city. According to the recently released Socio-Economic Outlook 2018, sector-wise analysis of merchandise...

• India
• Export

India’s drug regulatory body, Central Drugs Standard Control Organisation (CDSCO), is reportedly creating a national digital database of pharmaceutical manufacturers and their medicines so that regulators can be more effective when acting on problems...

• India
• Pharma